ImmunoGen Balance Sheet Health
Financial Health criteria checks 4/6
ImmunoGen has a total shareholder equity of $561.6M and total debt of $72.1M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are $822.1M and $260.5M respectively.
Key information
12.8%
Debt to equity ratio
US$72.11m
Debt
Interest coverage ratio | n/a |
Cash | US$605.54m |
Equity | US$561.60m |
Total liabilities | US$260.51m |
Total assets | US$822.10m |
Recent financial health updates
ImmunoGen (NASDAQ:IMGN) Is Using Debt Safely
Oct 20Is ImmunoGen (NASDAQ:IMGN) In A Good Position To Deliver On Growth Plans?
Feb 25Recent updates
Final Countdown: AbbVie's Imminent Closure With ImmunoGen And What It Means
Feb 09ImmunoGen, Inc.'s (NASDAQ:IMGN) Intrinsic Value Is Potentially 40% Above Its Share Price
Jan 09There's Reason For Concern Over ImmunoGen, Inc.'s (NASDAQ:IMGN) Massive 95% Price Jump
Dec 22ImmunoGen (NASDAQ:IMGN) Is Using Debt Safely
Oct 20Analysts Just Made A Massive Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN) Forecasts
Aug 06Is ImmunoGen, Inc. (NASDAQ:IMGN) Trading At A 48% Discount?
Jul 20Forecast: Analysts Think ImmunoGen, Inc.'s (NASDAQ:IMGN) Business Prospects Have Improved Drastically
May 03ImmunoGen, Inc.'s (NASDAQ:IMGN) Low P/S No Reason For Excitement
Apr 18Is ImmunoGen (NASDAQ:IMGN) In A Good Position To Deliver On Growth Plans?
Feb 25What Does The Future Hold For ImmunoGen, Inc. (NASDAQ:IMGN)? These Analysts Have Been Cutting Their Estimates
Jan 03Financial Position Analysis
Short Term Liabilities: IMGN's short term assets ($766.9M) exceed its short term liabilities ($134.7M).
Long Term Liabilities: IMGN's short term assets ($766.9M) exceed its long term liabilities ($125.8M).
Debt to Equity History and Analysis
Debt Level: IMGN has more cash than its total debt.
Reducing Debt: IMGN's debt to equity ratio has increased from 4.4% to 12.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMGN has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if IMGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.